Table 1 Baseline characteristics of ARAS and non-ARAS patients
|  | TOTAL N = 170 | ARAS N = 85 | Non-ARAS N = 85 | P value |
|---|---|---|---|---|
Age (year) | 69.00 (62.00 – 75.00) | 72.00 (64.00 – 76.00) | 68.00 (61.00 – 74.00) | 0.062 |
Male | 110 (64.71) | 57 (67.06) | 53 (62.35) | 0.521 |
Body Mass Index (kg/m2) | 23.93 (22.15 – 25.82) | 23.73 (21.64 – 25.78) | 24.03 (22.59 – 26.12) | 0.214 |
Current smoking | 51 (30.00) | 30 (35.29) | 21 (24.71) | 0.132 |
Systolic blood pressure (mmHg) | 147.08 ± 24.01 | 151.72 ± 26.66 | 142.44 ± 20.14 | 0.011 |
Diastolic blood pressure (mmHg) | 77.64 ± 11.57 | 77.79 ± 11.58 | 77.48 ± 11.63 | 0.864 |
Diabetes mellitus | 68 (40.00) | 33 (38.82) | 35 (41.18) | 0.754 |
Coronary artery disease | 139 (81.76) | 63 (74.12) | 76 (89.41) | 0.010 |
Peripheral arterial disease | 43 (25.29) | 28 (32.94) | 15 (17.65) | 0.022 |
Antihypertensive | 166 (97.65) | 83 (97.65) | 83 (97.65) | 1.000* |
 ACEIs/ARBs | 134 (78.82) | 62 (72.94) | 72 (84.71) | 0.060 |
 β-receptor blockers | 121 (71.18) | 59 (69.41) | 62 (72.94) | 0.611 |
 Calcium channel blockers | 84 (49.41) | 51 (60.00) | 33 (38.82) | 0.006 |
 Diuretics | 47 (27.65) | 23 (27.06) | 24 (28.24) | 0.864 |
 α-receptor blockers | 11 (6.47) | 9 (10.59) | 2 (2.35) | 0.057* |
Statin | 10 (5.88) | 4 (4.71) | 6 (7.06) | 0.746* |